Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases

Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases

Traditional Chinese medicine injections (TCMIs) have played an irreplaceable role for treating some clinical emergency, severe illness, and infectious diseases in China. In recent years, the incidence rates of adverse drug reactions (ADRs) of TCMIs have increased year by year. Danhong injection (DHI...

Full description

Bibliographic Details
Main Authors:	Xue-Lin Li, Jin-Fa Tang, Wei-Xia Li, Chun-Xiao Li, Tao Zhao, Bu-Chang Zhao, Yong Wang, Hui Zhang, Xiao-Fei Chen, Tao Xu, Ming-Jun Zhu
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2015/610846

Similar Items

Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies
by: A. Anil Sinaci, et al.
Published: (2015-01-01)

Identification of a Quality Marker (Q-Marker) of Danhong Injection by the Zebrafish Thrombosis Model
by: Yuqing Qi, et al.
Published: (2017-08-01)

Protective effect of Danhong injection on retina of diabetic rats
by: Hai-Yan Fan, et al.
Published: (2019-06-01)

Postmarket sequential database surveillance of medical products
by: Maro, Judith C
Published: (2013)

Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan
by: Shoko Takahashi, et al.
Published: (2016-01-01)

Self-controlled methods for postmarketing drug safety surveillance in large-scale longitudinal data
by: Simpson, Shawn E.
Published: (2011)

Sleep-walking with zolpidem: Need for continued postmarketing surveillance
by: Ajitha Sharma, et al.
Published: (2015-01-01)

Current development in medical devices postmarket surveillance in Taiwan
by: Cheng-Wen Lan, et al.
Published: (2015-03-01)

An Overview of Systematic Reviews of Danhong Injection for Ischemic Stroke
by: Hui Wang, et al.
Published: (2016-01-01)

An Overview of Meta-Analyses of Danhong Injection for Unstable Angina
by: Xiaoxia Zhang, et al.
Published: (2015-01-01)

Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke
by: Min Li, et al.
Published: (2018-04-01)

Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children
by: Jody L. Green, et al.
Published: (2018-12-01)

Safety and tolerability of fluvastatin XL in the treatment of hyper-cholesterolemia : a postmarketing surveillance conducted in Indonesia
by: Arini Setiawati, et al.
Published: (2008-05-01)

Danhong Injection Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through the Suppression of the Neuroinflammation
by: Haixia Du, et al.
Published: (2021-04-01)

Clinical efficacy and safety of alemtuzumab in postmarketing practice
by: N. V. Khachanova
Published: (2019-06-01)

Postmarketing surveillance of sumatriptan : patient population, efficacy, and adverse effects
by: Wang, Yu-Chin Lily
Published: (1994)

Rotavirus Vaccine Withdrawal in the United States: The Role of Postmarketing Surveillance
by: Gilles Delage
Published: (2000-01-01)

Danhong Injection Protects Hemorrhagic Brain by Increasing Peroxiredoxin 1 in Aged Rats
by: Shang Wang, et al.
Published: (2020-03-01)

Renoprotective Effect of Danhong Injection on Streptozotocin-Induced Diabetic Rats through a Peroxisome Proliferator-Activated Receptor γ Mediated Pathway
by: Xue Yang, et al.
Published: (2018-01-01)

Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations
by: Can Wang, et al.
Published: (2019-01-01)

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
by: Alexander W. Pastuszak, MD, PhD, et al.
Published: (2020-06-01)

Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
by: YiZhuo Li, et al.
Published: (2020-06-01)

Danhong Injection Alleviates Postoperative Intra-abdominal Adhesion in a Rat Model
by: Yunhua Wu, et al.
Published: (2019-01-01)

Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance.
by: Daniel B Kramer, et al.
Published: (2012-01-01)

Postmarket surveillance of 3D-printed implants for sacroiliac joint fusion
by: Cher D, et al.
Published: (2018-09-01)

A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
by: Rod P. Bonello, et al.
Published: (2014-01-01)

Protective Effect of Danhong Injection on Acute Hepatic Failure Induced by Lipopolysaccharide and D-Galactosamine in Mice
by: Ying Wang, et al.
Published: (2014-01-01)

Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India
by: Unnikrishnan Nair, et al.
Published: (2020-10-01)

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
by: Katagiri H, et al.
Published: (2018-01-01)

Pharmacological Mechanisms Underlying the Therapeutic Effects of Danhong Injection on Cerebral Ischemia
by: Yifei Qi, et al.
Published: (2021-01-01)

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
by: Chunxiao Li, et al.
Published: (2018-10-01)

PET Demonstrates Functional Recovery after Treatment by Danhong Injection in a Rat Model of Cerebral Ischemic-Reperfusion Injury
by: Zefeng Wang, et al.
Published: (2014-01-01)

Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial
by: Jun Liu, et al.
Published: (2021-09-01)

Effect of Danhong injection combined with irbesartan on oxidative stress and renal function damage in patients with diabetic nephropathy
by: Zhen Dong, et al.
Published: (2017-08-01)

The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
by: Jun-Bo Zou, et al.
Published: (2018-06-01)

Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway
by: Si-Nai Li, et al.
Published: (2019-12-01)

Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis
by: Yasuhiro Takeuchi, et al.
Published: (2018-03-01)

Alteration of Amino Acid Profiling Influenced by the Active Ingredients of DanHong Injection After Prescription Optimization
by: Guo Z, et al.
Published: (2019-11-01)

Danhong Injection Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells in Myocardial Infarction by Promoting Angiogenesis
by: Jingrui Chen, et al.
Published: (2018-07-01)

Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations
by: Wang C, et al.
Published: (2018-04-01)

Cannot write session to /tmp/vufind_sessions/sess_54qv2ue3mvctbffrupgrdq6gs1